Define Optimal 2nd Line Treatment and Sequence: Subgroup Analysis from Pivotal Studies and Real World Data - 100098

Spotlight
Video

Define Optimal 2nd Line Treatment and Sequence: Subgroup Analysis from Pivotal Studies and Real World Data

kidneycancer has 473 videos Subscribe Here

Loading........
Description: David McDermott, MD of the Dana-Farber/Harvard Cancer Center outlines and Defines Optimal 2nd Line Treatment and Sequence: Subgroup Analysis from Pivotal Studies and Real World Data at the  12th European International Kidney Cancer Symposium 2017
Shared By : kidneycancer
Posted on : 04/25/17
Added : 1 year ago
Category : Kidney Cancer